Global Peptide Based Gastrointestinal Disorders Therapeutics Market Insights and Forecast to 2031

Report ID: 1380535 | Published Date: Oct 2024 | No. of Page: 91 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Teduglutide
        1.2.3 Linaclotide
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Perspective (2017-2028)
    2.2 Peptide Based Gastrointestinal Disorders Therapeutics Growth Trends by Region
        2.2.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Dynamics
        2.3.1 Peptide Based Gastrointestinal Disorders Therapeutics Industry Trends
        2.3.2 Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers
        2.3.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges
        2.3.4 Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue
        3.1.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Peptide Based Gastrointestinal Disorders Therapeutics Revenue
    3.4 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio
        3.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2021
    3.5 Peptide Based Gastrointestinal Disorders Therapeutics Key Players Head office and Area Served
    3.6 Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
    3.7 Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Type
    4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2023-2028)
5 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Application
    5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2017-2028)
    6.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
        6.2.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2017-2028)
    6.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
        6.3.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2017-2028)
    6.4 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country
        6.4.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2017-2028)
    7.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
        7.2.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
        7.3.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country
        7.4.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2017-2028)
    9.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
        9.2.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
        9.3.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country
        9.4.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Takeda
        11.1.1 Takeda Company Details
        11.1.2 Takeda Business Overview
        11.1.3 Takeda Peptide Based Gastrointestinal Disorders Therapeutics Introduction
        11.1.4 Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022)
        11.1.5 Takeda Recent Developments
    11.2 Ironwood Pharmaceuticals
        11.2.1 Ironwood Pharmaceuticals Company Details
        11.2.2 Ironwood Pharmaceuticals Business Overview
        11.2.3 Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Introduction
        11.2.4 Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022)
        11.2.5 Ironwood Pharmaceuticals Recent Developments
    11.3 Astellas Pharma
        11.3.1 Astellas Pharma Company Details
        11.3.2 Astellas Pharma Business Overview
        11.3.3 Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Introduction
        11.3.4 Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022)
        11.3.5 Astellas Pharma Recent Developments
    11.4 Allergan
        11.4.1 Allergan Company Details
        11.4.2 Allergan Business Overview
        11.4.3 Allergan Peptide Based Gastrointestinal Disorders Therapeutics Introduction
        11.4.4 Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022)
        11.4.5 Allergan Recent Developments
    11.5 Takeda Pharmaceutical
        11.5.1 Takeda Pharmaceutical Company Details
        11.5.2 Takeda Pharmaceutical Business Overview
        11.5.3 Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Introduction
        11.5.4 Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022)
        11.5.5 Takeda Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Teduglutide
    Table 3. Key Players of Linaclotide
    Table 4. Key Players of Others
    Table 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2023-2028)
    Table 11. Peptide Based Gastrointestinal Disorders Therapeutics Market Trends
    Table 12. Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers
    Table 13. Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges
    Table 14. Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints
    Table 15. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Share by Players (2017-2022)
    Table 17. Global Top Peptide Based Gastrointestinal Disorders Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2021)
    Table 18. Ranking of Global Top Peptide Based Gastrointestinal Disorders Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
    Table 22. Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Share by Application (2017-2022)
    Table 30. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Share by Application (2023-2028)
    Table 32. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Takeda Company Details
    Table 63. Takeda Business Overview
    Table 64. Takeda Peptide Based Gastrointestinal Disorders Therapeutics Product
    Table 65. Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Takeda Recent Developments
    Table 67. Ironwood Pharmaceuticals Company Details
    Table 68. Ironwood Pharmaceuticals Business Overview
    Table 69. Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Product
    Table 70. Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Ironwood Pharmaceuticals Recent Developments
    Table 72. Astellas Pharma Company Details
    Table 73. Astellas Pharma Business Overview
    Table 74. Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Product
    Table 75. Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Astellas Pharma Recent Developments
    Table 77. Allergan Company Details
    Table 78. Allergan Business Overview
    Table 79. Allergan Peptide Based Gastrointestinal Disorders Therapeutics Product
    Table 80. Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Allergan Recent Developments
    Table 82. Takeda Pharmaceutical Company Details
    Table 83. Takeda Pharmaceutical Business Overview
    Table 84. Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Product
    Table 85. Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Takeda Pharmaceutical Recent Developments
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Teduglutide Features
    Figure 3. Linaclotide Features
    Figure 4. Others Features
    Figure 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Pharmacies Case Studies
    Figure 7. Retail Pharmacies Case Studies
    Figure 8. Online Pharmacies Case Studies
    Figure 9. Peptide Based Gastrointestinal Disorders Therapeutics Report Years Considered
    Figure 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2021
    Figure 16. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 18. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 19. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Country (2017-2028)
    Figure 20. United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Country (2017-2028)
    Figure 26. Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Region (2017-2028)
    Figure 36. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Country (2017-2028)
    Figure 46. Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Country (2017-2028)
    Figure 52. Turkey Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Takeda Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022)
    Figure 56. Ironwood Pharmaceuticals Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022)
    Figure 57. Astellas Pharma Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022)
    Figure 58. Allergan Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022)
    Figure 59. Takeda Pharmaceutical Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takeda
Ironwood Pharmaceuticals
Astellas Pharma
Allergan
Takeda Pharmaceutical
Frequently Asked Questions
Peptide Based Gastrointestinal Disorders Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Peptide Based Gastrointestinal Disorders Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Peptide Based Gastrointestinal Disorders Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports